Creo Medical, Inc

Creo Medical is a UK-based medical device manufacturer specializing in minimally invasive electrosurgical instruments for therapeutic endoscopy. Founded in 2001 and headquartered in Chepstow, Wales, the company designs and markets advanced energy devices utilizing proprietary Kamaptive® Technology, which combines high-frequency microwave and bipolar radiofrequency energy. The product portfolio spans gastroenterology, urology, and pulmonology applications, featuring flagship devices such as the Speedboat Inject (resection), MicroBlate ablation systems, and specialized endoscopic accessories. Creo Medical holds 318 patents globally and operates 14 offices across nine countries. The company has achieved FDA and CE Mark regulatory clearances and demonstrates strong clinical adoption, including NHS supply chain qualification with documented cost savings (£687k over 12 months in pilot programs). The product range encompasses diagnostic tools (biopsy forceps, capsule endoscopy systems), therapeutic instruments (polypectomy snares, extraction devices, hemoclips), and hygiene components for endoscope maintenance.